search
central nervous system
Trends
- 1FDA approves Teva's monthly olanzapine injection for schizophrenia●FDA approves Teva’s monthly injection of olanzapine for schizophrenia
The US Food and Drug Administration has approved Teva's long-acting injectable formulation of olanzapine for treating schizophrenia, the company announced. The monthly injection, known as olanzapine extended-release injectable suspension, offers patients a once-monthly maintenance option instead of daily oral medication. Teva, headquartered in Israel, has been expanding its pipeline of branded and generic neurological treatments, and the approval adds to its central nervous system portfolio.
- 2Educator shares free video course on the human nervous system●My video on the (human) central and peripheral nervous systems (part of a whole course on the study of cognition): https
A lesson covering the human central and peripheral nervous systems is circulating among science enthusiasts, presented as part of a full course on the study of cognition. The material introduces how the brain, spinal cord and nerves interact, and is tagged for audiences interested in psychology, neurology and brain science.
- 3CNS Drug Stocks in Focus on World Mental Health Day●4 CNS Drug Stocks Worth Watching This World Mental Health Day
World Mental Health Day is putting a spotlight on companies developing central nervous system drugs. A financial rundown highlights four CNS-focused stocks that investors may want to watch, tying renewed attention on mental health treatment to potential opportunities in the pharmaceutical sector. The item names no specific companies in the available reporting.